SEER - NASDAQ
Seer, Inc.
$1.86
-0.26%Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
At a Glance
Live SnapshotSeer, Inc. Management Team
Dr. Serafim Batzoglou Ph.D.
Chief Data Officer
Kenny Ross
Chief Operations & Product Officer
Ms. Marissa Dixon
Chief People Officer
Dr. Omid C. Farokhzad M.D., Ph.D.
Founder, Chief Executive Officer, & Chair of the Board of Directors
Compensation
$1,189,574
Mr. David R. Horn
President,Treasurer & Chief Financial Officer
Compensation
$746,652
Mr. Martin Goldberg Ph.D.
Senior Vice President of Product Development
Dr. Asim Siddiqui Ph.D.
Senior Vice President of Research & Tech Development
Seer, Inc. Insider Positioning
During the last 12 months, insiders have purchased $321K and sold $303K worth of SEER shares, resulting in $18K of net buying activity.
3 Months
0
0.00
7.3K
12.35K
-12K
-$12K
3-6 Months
0
0.00
32.1K
64.09K
-64K
-$64K
6-9 Months
0
0.00
40.6K
80.11K
-80K
-$80K
9-12 Months
147.4K
321.37K
71.1K
146.37K
+175K
+$175K
Top Buyers
Mcguire Terrance
Director
$66K
Langer Robert
Director
$66K
Gulyani Meeta
Director
$66K
Nishar Dipchand
Director
$66K
Roelofs Nicolas H Phd
Director
$55K
Top Sellers
Farokhzad Omid
Director, Officer: Ceo And Chair
$185K
Nishar Dipchand
Director
$63K
Horn David R.
Officer: President & Cfo
$55K
Insider Activity Analysis
Net Insider Sentiment
Moderately bullish with $18K net buying. Insiders show cautious optimism through measured share purchases.
Buy/Sell Ratio
Positive buy/sell ratio. Buying exceeds or matches selling, indicating net positive insider sentiment.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
5 insider buyers vs. 3 sellers. More insiders buying than selling indicates positive sentiment.
Insider Activity Insight
Broad-based insider buying: When multiple insiders independently decide to purchase shares, it often reflects genuine confidence rather than coordinated optics. This pattern deserves attention, especially if buying followed a price decline.
SEC Filings
SEER - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | May 28, 2025 | May 28, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | April 26, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 28, 2023 | April 28, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 28, 2022 | April 28, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 28, 2021 | April 28, 2021 | 2021 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.